STOCK TITAN

SAIC (SAIC) director David Urban receives 1,886-share stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Urban David reported acquisition or exercise transactions in this Form 4 filing.

Science Applications International Corp director David Urban received a grant of 1,886 shares of Common Stock. The award was recorded at a price of $0.00 per share, reflecting a compensation grant rather than a market purchase. Following this grant, he directly holds 3,139 shares of SAIC common stock.

Positive

  • None.

Negative

  • None.

Insights

Director received routine stock grant, increasing direct SAIC share holdings.

Director David Urban was granted 1,886 shares of Science Applications International Corp Common Stock at a stated price of $0.00 per share. The transaction code A and description "Grant, award, or other acquisition" indicate this is a compensation-related equity award, not an open-market purchase.

After the grant, Urban directly holds 3,139 shares. There are no derivative positions reported in this filing and no sales or dispositions. As a single equity award with no accompanying trades, this appears to be a routine element of director compensation rather than a thesis-changing event.

Insider Urban David
Role null
Type Security Shares Price Value
Grant/Award Common Stock 1,886 $0.00 --
Holdings After Transaction: Common Stock — 3,139 shares (Direct, null)
Footnotes (1)
Shares granted 1,886 shares Common Stock grant coded A as award acquisition
Grant price per share $0.00 per share Stated price for compensation-related stock grant
Shares held after grant 3,139 shares Total direct SAIC Common Stock holdings post-transaction
Transactions acquiring shares 1 transaction Single Form 4 acquisition with code A
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Urban David

(Last)(First)(Middle)
12010 SUNSET HILLS ROAD

(Street)
RESTON VIRGINIA 20190

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Science Applications International Corp [ SAIC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026A1,886A$03,139D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
Hilary L. Hageman, Attorney-in-fact06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did SAIC director David Urban report in this Form 4 filing for SAIC?

David Urban reported receiving a grant of 1,886 shares of Science Applications International Corp Common Stock. The shares were acquired at a stated price of $0.00 per share, reflecting an equity compensation award rather than a market transaction.

How many SAIC shares does David Urban hold after this reported grant?

After the grant, David Urban directly holds 3,139 shares of Science Applications International Corp Common Stock. This total reflects his updated ownership position following the 1,886-share compensation award disclosed in the Form 4 insider filing.

Was David Urban’s SAIC transaction an open-market buy or a compensation grant?

The transaction was a compensation grant, not an open-market buy. It is coded "A" with the description "Grant, award, or other acquisition" and shows a price of $0.00 per share, typical of equity awards to directors.

Did David Urban sell any Science Applications International Corp shares in this Form 4?

No sales were reported in this Form 4. The filing shows only one acquisition transaction, a grant of 1,886 SAIC Common Stock shares, with no corresponding dispositions or derivative exercises disclosed in the transaction summary.

Does this SAIC Form 4 show any options or other derivative positions for David Urban?

The filing shows no derivative positions for David Urban. The derivativeSummary is empty, and the only reported transaction involves non-derivative Common Stock, indicating this update relates solely to a share grant and not to options or similar instruments.